Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary IgA Nephropathy: Multi-center, Multi-arm and Multi-stage

NCT06676384 is registered in ClinicalTrials.gov with Christian Medical College, Vellore, India as lead sponsor.

NCT NCT06676384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary IgA Nephropathy: Multi-center, Multi-arm and Multi-stage
Lead sponsor
Christian Medical College, Vellore, India
Phase
Phase 4
Overall status
Recruiting
Start date
February 15, 2025
Completion date
August 31, 2029
Enrollment
585 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

iga glomerulonephritis, iga nephropathy, iga vasculitis, renal insufficiency, chronic